No. | Control group n = 95 | CPP group n = 52 | PPP group n = 23 | P |
---|---|---|---|---|
Female (%) | 109 (55.9 %) | 47 (90.38 %) | 23 (100 %) | <.001a (Control vs CPP, PPP) |
Age (year) | ||||
Pediatric evaluation | 10.5 ± 2.9 | 8.3 ± 0.5 | 8.0 ± 1.1 | <.001b (Control vs CPP) .023b (Control vs PPP) |
Dental evaluation | 12.0 ± 4.4 | 8.9 ± 2.3 | 9.6 ± 3.3 | <.001b (Control vs CPP, PPP) |
Prevalence | ||||
Maxillary DDAs | 43 (22.05 %) | 26 (50.00 %) | 5 (21.74 %) | <.001a (Control vs CPP) 1.000a (Control vs PPP) <.029a (CPP vs PPP) |
Mesiodens | 26 (13.33 %) | 22 (42.31 %) | 5 (21.74 %) | <.001a (Control vs CPP) .732a (Control vs PPP) <.049a (CPP vs CPP) |
Except mesiodens | 17 (8.71 %) | 4 (7.69 %) | 0 | 0.317c |